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 ABSTRACT 
 
 
Background 
Vitamin B12 deficiency (<148 pmol/L) and insufficiency (<221 pmol/L) constitute a 
global health problem, particularly in low-income settings and among children, 
women of reproductive age, and the elderly. There have been few Latin American 
national surveys to examine the burden of vitamin B12 deficiency and vitamin B12 
insufficiency.  The 2012 Ecuadorian National Survey of Health and Nutrition is a 
nationally-representative complex survey of the Ecuadorian population and provides 
the first national estimate of vitamin B12 status in Ecuador.  
 
Methods 
Vitamin B12 was measured in 16,152 people from 10 to 59 years of age. Association of 
vitamin B12 status and levels with different socio-demographic and anthropometric 
correlates (sex, age, area, region, economic quintile, education level, ethnicity, and 
body mass index) was explored with univariate and multivariate linear and logistic 
regression models using survey procedures in SAS 9.4. 
 
Results 
The prevalence of vitamin B12 deficiency and vitamin B12 insufficiency in the overall 
Ecuadorian population was 5.4% and 27.4%, respectively. The burden was highest 
among pregnant women (21% and 55%). In the multivariate analyses, sex, age, region, 
 education level, economic quintile, and ethnicity were significantly associated with 
vitamin B12 status. Men had higher odds of vitamin B12 insufficiency when compared 
to women (OR 1.5, 95% CI 1.35-1.66). Individuals  living in the coastal regions had  
higher natural logarithmically transformed vitamin B12 concentrations (β=0.21, 
p<0.0001) and lower odds of vitamin B12 deficiency (OR: 0.56, 95% CI: 0.44-0.72) 
and insufficiency (OR: 0.48, 95% CI 0.41-0.57) when compared to people living in the 
highlands.  
 
Conclusions 
Vitamin B12 insufficiency is a significant health problem in Ecuador. Information is 
lacking to estimate the burden of vitamin B12 deficiency and vitamin B12 insufficiency 
for significant risk groups such as infants, children <10y, pregnant and lactating 
women, and the elderly. Prospective studies are needed to determine the association of 
total vitamin B12 insufficiency with adverse health outcomes in this population.
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INTRODUCTION 
 
 
Biochemistry of vitamin B12 
 
Vitamin B12, also known as cobalamin, is a water-soluble essential nutrient found 
exclusively in animal-source foods (1). In humans, vitamin B12 functions as a cofactor 
for two enzymes: methyl malonyl coenzyme A (CoA) mutase and methionine synthase 
(MS). Methyl malonyl CoA mutase is contained in the mitochondria and utilizes 
adenosylcobalamin to convert methyl malonyl CoA to succinyl CoA, a metabolite in 
the tricarboxylic acid cycle. The dysfunction or lack of methyl malonyl CoA mutase, 
or the absence of vitamin B12, result in the accumulation of methyl malonic acid (2-4).  
 
On the other hand, methionine synthase utilizes methylcobalamin to catalyze, in the 
cytoplasm, the remethylation of homocysteine to methionine. Methionine is then 
integrated in S-adenosyl methionine (SAM), a methyl donor required in more than a 
hundred reactions, some of which include DNA synthesis and repair and methylation.   
 
In animal-source foods, vitamin B12 is bound to protein and must be released before 
absorption. This process is facilitated by the acid environment of the stomach. 
Intrinsic factor is produced by the parietal cells of the stomach and is essential for the 
absorption of vitamin B12 in the ileum. In circulation, vitamin B12 is bound to 
haptocorrin (70-90%) or transcobalamin (10-30%) (1, 4). Transcobalamin-bound 
vitamin B12 (also called holotranscobalamin) is the active form of vitamin B12 because 
it can enter the cells (5) via the transcobalamin receptor, CD320. (5, 6).  
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Deficiency or insufficiency of vitamin B12 lead to a deficit of one or both of its 
cofactor forms (i.e. adenosylcobalamin and methylcobalamin) intracellularly, which 
results in the impaired function of vitamin B12-dependent enzymes. This disfunction, 
in turn, leads to impaired purine and thymidylate synthesis, as well as deficient 
methylation reactions due to insufficient SAM. These metabolic alterations result in a 
variety of signs and symptoms such as megaloblastic anemia and neurological, and 
cognitive abnormalities. Although the exact mechanisms that cause these 
manifestations have not been completely elucidated, faulty DNA synthesis and 
regulation(7, 8), and increased cellular stress and production of reactive oxygen 
species have been suggested as possible causes(9-11).  
 
Vitamin B12 status is measured by circulating (total vitamin B12 and 
holotranscobalamin) and functional (methyl malonic acid and homocysteine) 
biomarkers (12, 13). Total vitamin B12 is the most commonly used biomarker for 
assessing vitamin B12 status (12). Vitamin B12 deficiency is and vitamin B12 
insufficiency are commonly defined as total vitamin B12< 148 pmol/L and <221 
pmol/L, respectively (14). 
 
Vitamin B12 deficiency  
Vitamin B12 deficiency was first recognized in the context of pernicious anemia,  an 
autoimmune disorder that impairs vitamin B12 absorption due to the destruction of the 
gastric cells that produce intrinsic factor (4). The classic presentation of vitamin B12 
deficiency is megaloblastic anemia and neurologic alterations (10, 13) and this has 
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been deemed relatively rare (10). On the other hand, vitamin B12 insufficiency (<221 
pmol/L) in the absence of overt clinical symptoms (i.e. subclinical vitamin B12 
deficiency) is more common (10) and has been identified as a potential health risk due 
to its increased susceptibility to vitamin B12 deficiency-associated adverse health 
outcomes  (10, 12, 14-16).  
 
There is evidence that a low vitamin B12 status during pregnancy is associated with 
adverse pregnancy outcomes and childhood development outcomes (12, 17), including 
intrauterine growth restriction, preeclampsia, and neural tube defects (18). Low 
vitamin B12 levels have also been associated with impaired cognitive function in 
children (17) and cognitive decline later in life (10, 19). 
 
Risk factors of vitamin B12 deficiency  
In high-income countries, vitamin B12 deficiency or insufficiency is most prevalent in 
the elderly (20)  due to various causes such as decreased intake of animal products and 
malabsorption as a result of pernicious anemia, gastrointestinal surgery, chronic 
gastritis, and antacid drugs  (10, 21). On the other hand, in low-income settings, the 
main cause of vitamin B12 deficiency is insufficient dietary intake resulting from a 
limited access to animal-source foods and exacerbated by gastrointestinal infections 
and parasitic infestations (4, 10, 20-22). In these settings, groups children, pregnant 
women, and women of reproductive age are particularly vulnerable (10, 20, 23). 
 
 
  4
Burden of vitamin B12 deficiency 
The prevalence of vitamin B12 deficiency (<148 pmol/L) worldwide is widely variable 
according to age group and country setting. It ranges from as low as 1-4% in the 
general US (20, 24, 25) and Europe(10) to as high as 50% in Indian adults(10). 
Vitamin B12 insufficiency (<221 pmol/L) is more common, ranging from ~15% in the 
US(20) to 80% in India(10). In the US, the prevalence of vitamin B12 deficiency and 
vitamin B12 is higher in the elderly (≥70 y) compared to the general population (~6% 
and ~25%, respectively) (10, 20, 26) 
 
Vitamin B12 deficiency or insufficiency is more common in Asian and African 
countries compared to European and North American settings(10, 20, 26). In Latin 
America several local and national studies have assessed the prevalence of vitamin B12 
deficiency, ranging from 2.9% in Costa Rican Adult men to ~38% in Guatemalan 
women of reproductive age, and vitamin B12 insufficiency, ranging from 21% in 
Colombian children (<18y) to 68.2% in Guatemalan women of reproductive age.  
 
In Ecuador, the DANS (27) and Endemain (28) National surveys aimed to assess 
maternal and child health from 1986 to 2004. Neither of these surveys measured 
serum vitamin B12. More recently, the SABE(29) survey assessed the health of the 
elderly (≥60 y) Ecuadorian population and included an analysis of vitamin B12 levels. 
The prevalence of vitamin B12 deficiency (<148 pmol/L) was 13.5% in men and 6.6% 
in women, while, overall 31% of the elderly population was vitamin B12 insufficient 
(<221 pmol/L). 
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ENSANUT-ECU is the first Ecuadorian Nationally-representative survey to address 
the entire population (0-59y). There is currently no information on the national 
prevalence of vitamin B12 deficiency and insufficiency in Ecuador. Therefore, the 
objective of this analysis was to examine the burden of vitamin B12 deficiency and 
insufficiency in the Ecuadorian population. 
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METHODS 
 
Study Population 
The National Health and Nutrition Survey from Ecuador (ENSANUT-ECU) is a 
nationally-representative complex survey of the Ecuadorian population that was 
conducted in 2012 to 92,502 individuals. The methods have been described in detail 
elsewhere (30-32). Briefly, the sample design was probabilistic, multistage, stratified, 
and clustered. The sample was representative at the national and regional levels.  
 
Assessed variables included home and socio-demographic characteristics, sexual and 
reproductive behaviors and history, access to health care services, and health history. 
The nutrition component of the survey included biochemical analysis, food intake, 
anthropometric measurements, and breastfeeding and complimentary feeding 
practices. Informed consent was obtained from all participants.  
 
A total of 19,949 homes were surveyed, which included 92,502 people. From each 
home, one participant was randomly selected from each group: one woman of 
reproductive age (12-49 years), one child younger than 5, one teenager (10-19 years), 
and one adult (20-59 years).   
 
All included members in the household, except people older than 59 years of age and 
pregnant women, were eligible for anthropometric survey. A random subsample of 
50% of the included homes was selected for the biochemistry survey (n=9,968 homes, 
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21,479 people). Vitamin B12 was analyzed on 16,152 samples from the target 
population of 10-59 years. The sample selection process is represented graphically in 
Figure 1. For this analysis, only the population with available vitamin B12 information 
was considered.  
 
Figure 1 Sample Selection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5-11 years 
(n=1,167) 
12-19 years 
(n=4,038) 
Anthropometry 
survey (n=3,985) 
Anthropometry 
survey (n=1,164) 
    Biochemical Survey 
               (n=21,479) 
Available vitamin B12 
levels (n=16,152) 
No vitamin B12 
(n=5,309) 
Children (≤19y) 
n=5,205 
Adults (20-59y) 
n=10,947 
5,305children <10 y 
 
Anthropometry 
survey (n=10,693) 
  8
Biochemical analyses  
Total vitamin B12 was measured in the population 10 to 59 years of age by automated 
chemiluminescence (Immulite 2000).  
 
Anthropometric measures 
For weight measurement for both children and adults, an electronic Seca 874 scale 
with mother/child function (tare), 200 kg capacity, and 50g precision was used. 
Participants were asked to remove shoes and heavy clothing prior to the measurement. 
Children younger than 2 years were weighed in their mother’s or primary caretaker’s 
arms and with either no diaper or a clean and dry diaper.  
 
Height was assessed with a Seca 217 stadiometer with a 20-205 cm range and 1 mm 
precision. Participants were asked to remove their shoes and hair accessories that 
could alter the measurement. Both parameters were measured in duplicate, and a third 
measurement was required when the difference between the first two was greater than 
0.5 cm or 0.5 kg. The final value was the mean of the two closest measurements. Field 
anthropometry personnel were trained and standardized prior to data collection.   
 
Vitamin B12 Status 
Vitamin B12 deficiency was defined as  vitamin B12 < 148 pmol/L and insufficiency 
was defined as vitamin B12 <221 pmol/L (14). 
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Definitions of variables 
Age was categorized by two methods. Firstly, for comparison purposes, ENSANUT-
ECU age categories are presented in table 1. These categories were defined for each 
decade from 20 to 60 years of age. Children were defined as ages 0-5 and 5-11, while 
adolescents were defined as 12-19 years of age. Age was also categorized in quintiles 
(Q1-Q5) for all analyses. Women of reproductive age were defined as non-pregnant 
females from 12 to 49 years of age.  
 
Economic quintile was established from an economic score obtained by considering 
42 variables pertaining to home characteristics and furnishings. Economic score has a 
normal distribution and quintiles were generated to categorize homes. The first 
economic quintile corresponds to the 20% homes with the lowest scores, while the 
fifth quintile includes the 20% of homes with the best economic conditions.  
 
Area was defined as urban for populations of over 2000 people and rural otherwise. 
Region was defined by grouping of the subregions defined ENSANUT-ECU authors 
(Urban coast, rural coast, urban highlands, rural highlands, urban amazon, rural 
amazon, Galapagos, Quito, and Guayaquil). Urban and rural highlands, as well as 
Quito were classified as the highlands region. Urban coast, rural coast, and Guayaquil 
were categorized as coast. Urban and rural Amazon were defined as Amazon, while 
Galapagos was the only subregion that was not grouped with any others and remained 
as a region category.  
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Ethnicity was self-reported by survey participants or their caretakers in four 
categories: Indigenous, Montubio, Afro-Ecuadorian, and Mestizo/White/others.  
 
Education level was self-reported into 10 categories: none, alphabetization center, 
preschool, elementary school, basic school, middle school, high-school, more than 
high school, college, graduate degree. For this analysis, these categories were grouped 
into four: none or incomplete elementary school, incomplete secondary, secondary, 
and more than secondary. 
  
For children (≤19 years), weight adequacy was assessed using the World Health 
Organization (WHO) body mass index (BMI) (kg/m2) for age z-scores (33, 34) with 
the 2007 (35) WHO downloadable SAS macro. Using the WHO-defined cut-offs (36), 
underweight was defined as a z-score < -2 standard deviations of the mean (SD). 
Normal weight was defined as a z-score ≥ -2 SD and ≤ +1 SD, overweight was defined 
as z-score > +1 SD and ≤ + 2 SD, and obesity was defined as z-score > + 2 SD.  
  
For adults (> 19 years), BMI was categorized using WHO cut-offs. Underweight was 
defined as BMI <18.5 kg/m2, normal weight was defined as BMI ≥18.5 and < 25 
kg/m2, overweight was defined as a BMI ≥25 and <30 kg/m2, and obesity was defined 
as BMI ≥30 kg/m2. 
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Statistical Analysis 
Descriptive statistics were calculated for the outcomes of interest and exposure 
variables (sex, age, area, economic quintile, region, education level, ethnicity, height, 
weight, body mass index). Outliers were defined as those greater than quartile 3 + 
3*IQR or lower than quartile 1- 3*IQR. Outliers were flagged but if deemed 
biologically plausible, were included in analyses. Descriptive statistics (mean, median, 
geometric mean) of vitamin B12 were calculated for each exposure variable of interest. 
A normal probability plot and Kolmogorov-Smirnov test showed that the distribution 
of vitamin B12 was not normal, hence vitamin B12 was natural logarithmically 
transformed for normality. Linear regression models were used to analyze the 
association between each exposure variable and the natural logarithmically 
transformed vitamin B12 concentrations. Logistic regression was conducted for 
categorical outcomes (i.e., vitamin B12 deficiency, vitamin B12 
sufficiency/insufficiency) for each individual exposure.  
 
In correlate analyses, variables were examined individually and then considered for 
inclusion in the complete model if their p-value was less than 0.20. Different versions 
of a single variable (for example, continuous and categorical age) were selected for 
inclusion in the final model according to their level of statistical significance. All 
variables with a p-value <0.20 where included in the model initially. A backward 
stepwise selection process was used to select the variables for the final model.   The 
variable with the largest p-value was removed in a stepwise manner until all included 
variables included were significant at the 0.05 level. Final linear models were checked 
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for normality using quantile-quantile plots and equal variance using predicted values 
and residual plots. Univariate and multivariate analyses were repeated for the children 
only (≤19y) and adult only (>19y) subgroups.  
 
Survey procedures (i.e. Survey Means, Survey Frequency, Survey Logistic, and 
Survey Reg) from SAS 9.4 were used for statistical analyses. The survey-specific 
variables were defined as follows: cluster was the census section, strata were the area 
(urban or rural), and the sample weight was the individual weight assigned to each 
survey participants. All variables were obtained from the publicly available 
biochemistry data set of ENSANUT-ECU. 
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RESULTS 
 
 
The characteristics of the whole ENSANUT-ECU sample (N=92,502), the 
biochemistry subsample (n=21,479), and the individuals with available vitamin B12 
levels (n=16,152) are presented in Table 1.  The main difference between these nested 
samples was the exclusion of people 60 years or older from the biochemical analysis 
and the fact that vitamin B12 was not analyzed in children younger than 10 years of 
age. Most of the Ecuadorian population (~80%) is of Mestizo, White, or other 
ethnicity and lives either in the coastal or highlands areas of the country (~94%). 
Women of reproductive age (n=8,996) represented 43.64% of the available vitamin 
B12 levels sample, while only 275 pregnant women were included in the biochemistry 
survey.  
 
Descriptive statistics for vitamin B12 (arithmetic mean (SE), median (IQR) and 
geometric mean (SE)) for different socio-demographic and anthropometric 
characteristics are summarized in Table 2. Female participants had higher geometric 
mean vitamin B12 levels than male participants (286.02 vs 311.11 pmol/L, 
respectively). In terms of age, quintile 2 (16-24y) had the lowest mean vitamin B12 
(geometric mean=281.17), while quintile 5 (>43y) had the highest mean vitamin B12 
(geometric mean: 326.38). 
 
No differences were found in vitamin B12 levels between urban and rural areas 
(geometric mean 287.06 and 286.33, respectively). 
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Table 1 Characteristics of the study population 
Variable, Mean (SE) or 
population estimate, thousands 
(%) 
Overall Sample Biochemistry subsample  Vitamin B12 subsample  
n missing 
(%) 
n 
Mean (SE) or  
Pop. Estimate 
in thousands 
(%) 
n mising 
(%) 
n  
Mean (SE) or  
Pop. Estimate 
in thousands 
(%) 
n missing 
(%) 
n  
Mean (SE) or  
Pop. Estimate in 
thousands (%) 
Total 
 
92502 15878 
 
21479 13473 
 
16152 10712 
Female 
 
47523 8139 (51.26) 
 
12920 6791 (50.4) 
 
10299 5647 (52.72) 
Socio-demographic 
         
Age 
 
92502 26.27 (0.14) 
 
21479 24.49 (0.19) 
 
16152 29.6 (0.17) 
Age category  4888* (5) 87614 
      
0-5 years 
 
11506 1787 (11.25) 
 
2047 1375 (10.21) 
 
0 - 
5-11 years 
 
15862 2528 (15.92) 
 
4443 2005 (14.88) 
 
1167∆ 623 (5.82) 
12-19 years 
 
16806 2791 (17.58) 
 
4039 2478 (18.39) 
 
4038 2477 (23.12) 
20-29 years 
 
15232 2615 (16.47) 
 
3762 2654 (19.69) 
 
3762 2654 (24.77) 
30-39 years 
 
12626 2216 (13.95) 
 
3795 2178 (16.17) 
 
3794 2178 (20.34) 
40-59 years 
 
9924 1834 (11.55) 
 
2644 1710 (12.69) 
 
2642 1706 (15.93) 
50-59 years  
 
5658 1127 (7.1) 
 
749 1074 (7.97) 
 
749 1074 (10.03) 
Age Quintiles** 
 
92502 
  
21479 
 
 
  
Q 1  20380 3201 (20.16)  5312 2751 (20.42)  3876 2262 (21.12) 
Q 2  20102 3276 (20.63)  4831 2877 (21.35)  3144 2231 (20.83) 
Q 3  18924 3244 (20.43)  3739 2604 (19.33)  3159 1963 (18.32) 
Q 4  16932 2996 (18.87)  4546 2679 (19.88)  3768 2233 (20.84) 
Q5  16164 3162 (19.91)  3051 2563 (19.02)  2205 2023 (18.89) 
Life stage 
         
Pregnant women  
 
782 115 (0.73) 
 
275 144 (1.07) 
 
275 144 (1.34) 
WRA (12-49 y)  
 
27902 4810 (30.3) 
 
8998 4682 (34.75) 
 
8996 4678 (43.64) 
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Table 1 (Continued)          
  Area± 
         
        Urban 
 
54092 58.48% 
 
13067 60.84% 
 
9959 61.66 
        Rural 
 
38410 41.52% 
 
8412 39.16% 
 
6193 38.34 
  Region 
         
        Highlands 
 
41896 7409 (46.66) 
 
9665 5942 (44.1) 
 
7508 4859 (45.36) 
        Coast 
 
24559 7647 (48.16) 
 
6209 6779 (50.31) 
 
4546 5296 (49.44) 
        Amazon 
 
23346 800 (5.04) 
 
4874 728 (5.41) 
 
3588 539 (5.04) 
        Galápagos 
 
2701 23 (0.14) 
 
731 24 (0.18) 
 
510 17 (0.16) 
Economic status index 214 (0.2) 
  
7 (0.1) 
  
7 
  
        Q1 
 
24654 3218 (20.27) 
 
5331 2935 (21.78) 
 
3801 2217 (20.71) 
        Q2 
 
21277 3274 (20.62) 
 
4898 2761 (20.5) 
 
3593 2090 (19.52) 
        Q3 
 
18010 3095 (19.49) 
 
4319 2618 (19.43) 
 
3250 2055 (19.2) 
        Q4 
 
15492 3160 (19.9) 
 
3760 2539 (18.84) 
 
2926 2102 (19.63) 
        Q5 
 
12855 3100 (19.52) 
 
3164 2615 (19.41) 
 
2575 2242 (20.94) 
  Ethnicity 2412 (2.4) 
        
        Indigenous 
 
10949 968 (6.1) 
 
2218 1156 (8.58) 
 
1676 905 (8.45) 
        Afro-Ecuadorian 
 
3662 671 (4.23) 
 
783 955 (7.09) 
 
577 758 (7.08) 
        Montubio 
 
2889 860 (5.41) 
 
776 1152 (8.55) 
 
561 868 (8.1) 
        Mestizo/white, /others 
 
72590 13002 (81.89) 
 
17702 10210 (75.78) 
 
13338 8181 (76.37) 
  Level of Education 13712 (13.5) 
  
2047 (10.2) 
     
        None/incomplete primary 
school  
2705 495 (3.12) 
 
333 269 (2) 
 
289 243 (2.26) 
        Primary school/incomplete secondary 51817 8501 (53.54) 
 
12696 7237 (53.71) 
 
9463 5881 (54.9) 
        Secondary school 
 
15772 2995 (18.86) 
 
4189 2918 (21.66) 
 
4188 2918 (27.24) 
        Greater than secondary 
school  
8496 1749 (11.01) 
 
2214 1674 (12.42) 
 
2212 1670 (15.59) 
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*The 4888 individuals missing age category are older adults (>59y), that were included in demographic survey but excluded from all other ENSANUT analyses. 
∆18 children <10y with available vitamin B12 levels were excluded from this analysis. 
**Cut-offs for age quantiles were defined for each subsample: Overall sample: 8y, 8-17y, 17-29y, 29-43y, >43y. Biochemistry subsample: <9y, 9-18y, 18-28y, 28-40y, >40y. Vitamin B12 subsample: <16y, 
16-24y, 24-32y, 32-43y, >43y.  
±Area (%) estimates are non-weighted. 
 ‡Adult BMI (kg/m2) was categorized by WHO cut-offs: underweight (<18.5), normal (18.5-24.9), overweight (25-29.9), and obese (≥30). Not overweight was BMI <25, overweight/obese was BMI ≥25. 
 Child BMI z-score was categorized by WHO cut-offs: underweight (<-2), normal (-2 - <1), overweight (1 - <2), and obese (>2). Not overweight was z-score <1, overweight/obese was z-score ≥1. 
Table 1 (Continued) 
Anthropometric          
Adults (>19 y) 48328 
  
10950 
  
10947 
 
  BMI (kg/m2) 18622 29706 27.07 (0.06) 254 (1.9) 10696 27.01 (0.09) 254 (1.9) 10693 27.01 (0.09) 
  BMI category‡ 18624 (40.4) 29704 
 
256 (2) 
  
256 (2) 
  
Underweight  
 
313 63 (0.71) 
 
131 98 (1.29) 
 
131 98 (1.31) 
 Normal  
 
10423 1805 (20.58) 
 
3637 2589 (34) 
 
3635 2588 (34.69) 
 Overweight  12404 2164 (24.66) 
 
4462 3093 (40.62) 
 
4462 3093 (41.46) 
 Obese  
 
6564 1197 (13.65) 
 
2464 1685 (22.12) 
 
2463 1682 (22.54) 
Overweight/obesity‡  18624 (40.4) 
  
256 (2) 
  
256 (2) 
  
Not overweight  
 
10736 1868 (21.3) 
 
3768 101 (35.28) 
 
3766 2686 (36) 
Overweight/obese 
 
18968 3361 (38.31) 
 
6926 160 (62.74) 
 
6925 4775 (64) 
Children (≤ 19 y)  44174 
  
10529 
  
5205 
 
BMI z-score CategoryΠ 19018 (42.9) 25156 
 
1331 (15.7) 
  
518 
(10.2)   
Underweight  
 
316 60 (0.85) 
 
107 64 (1.09) 
 
60 39 (1.26) 
Normal  
 
17855 2854 (40.17) 
 
6654 3558 (60.74) 
 
3437 2036 (65.67) 
Overweight  
 
4786 764 (10.75) 
 
1664 868 (14.82) 
 
852 501 (16.16) 
Obese 
 
2199 377 (5.31) 
 
773 451 (7.7) 
 
338 207 (6.68) 
Overweight/obesity Π 19018 (42.9) 
  
1331 (15.7) 
  
518 
(10.2)   
                 Not overweight 
 
18171 2915 (41.02) 
 
6761 3622 (61.83) 
 
3497 2075 (66.93) 
                Overweight/Obese 
 
6985 1141 (16.06) 
 
2437 1320 (22.53) 
 
1190 708 (22.84) 
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Table 2 Vitamin B12 concentrations by socio-demographic and anthropometric variables 
Variable n missing  n  Mean (SE)  Median (Q1, Q3) Geometric Mean (SE) 
Socio-demographic 
Sex 16152 
Male 5853 323.13 (5.67) 272.00 (204.24, 379.82) 286.02 (4.10) 
Female 10299 351.25 (4.49) 301.32 (224.33,419.89)  311.11 (3.34) 
Age Quintiles 
Q1 (<16y) 3876 326.08 (5.44) 282.22 (211.13,384.24)  292.58 (4.04) 
Q2 (16-24y) 3144 317.54 (6.51) 268.78 (198.49,383.40)  281.17 (4.72) 
Q3 (24-32y) 3159 324.46 (6.24) 274.51 (214.48,377.41)  290.14 (4.43) 
Q4 (32-43y) 3768 349.60 (6.53) 295.40 (221.73,416.22)  308.18 (4.75) 
Q5 (>43) 2205 373.97 (7.50) 318.28 (232.46,441.88)  326.38 (5.71) 
Life stage 
Pregnant women  275 258.47 (14.71) 212.30 (153.39,303.67)  225.63 (10.49) 
WRA (12-49 y)  8996 346.93 (4.76) 298.17 (224.17,411.90)  309.13 (3.52) 
Area± 
Urban 9959 323.28 (1.81) 275.22 (206.82,380.61)  287.06 (1.35) 
Rural 6193 320.11 (2.19) 275.99 (208.86,378.63)  286.33 (1.66) 
Region 
Highlands 7508 298.67 (3.64) 257.39 (198.72,345.47)  268.73 (2.73) 
Coast 4546 376.61 (7.72) 319.42 (233.55,459.43)  332.25 (5.98) 
Amazon 3588 309.91 (4.92) 264.01 (198.30,357.92)  275.87 (3.74) 
Galápagos 510 408.72 (29.01) 355.76 (248.30,515.37)  356.58 (23.54) 
Education 
None/less than primary 289 381.60 (19.10) 318.92 (239.49,446.61)  337.36 (13.00) 
Primary/less than secondary 9463 337.48 (4.86) 286.68 (213.36,404.23)  299.51 (3.65) 
Secondary 4188 343.43 (7.24) 286.96 (218.54,404.40)  301.94 (5.14) 
Greater than secondary 2212 323.70 (6.56) 276.97 (207.94,381.58)  287.01 (4.89) 
Economic quintile 7 
Q1 3801 340.98 (7.81) 289.95 (222.72,396.25)  304.08 (5.71) 
Q2 3593 345.26 (8.20) 294.59 (216.66,414.04)  304.22 (6.07) 
Q3 3250 345.74 (8.59) 283.37 (208.78,415.86)  301.93 (6.23) 
Q4 2926 337.34 (7.59) 288.02 (212.02,403.27)  298.05 (5.80) 
Q5 2575 321.11 (6.57) 276.64 (210.76,376.27)  287.25 (4.94) 
 
  18
±Area estimates are non-weighted. 
 
 
 
Table 2 (Continued) 
Ethnicity 
Indigenous 1676 307.32 (8.50) 266.32 (199.88,351.52)  276.58 (6.33) 
Afro-Ecuadorian 577 404.39 (16.29) 351.01 (237.07,499.69)  352.97 (12.74) 
Montubio 561 359.62 (13.67) 307.44 (231.15,439.50)  322.09 (10.28) 
Mestizo, white, other 13338 332.89 (4.52) 281.64 (211.77,395.16)  294.64 (3.35) 
Anthropometric 
Adults (>19 y) 
BMI Category  256 
Underweight (<18.5 kg/m2) 131 378.38 (25.50) 303.58 (222.06,448.10)  329.04 (20.74) 
Normal (18.5-24.9 kg/m2) 3635 334.47 (5.54) 286.44 (218.50,392.17)  297.75 (4.11) 
Overweight (25-29.9 kg/m2) 4462 345.13 (5.96) 285.90 (214.87,412.15)  302.45 (4.36) 
Obese (≥30 kg/m2) 2463 363.90 (7.99) 307.63 (225.30,438.93)  320.97 (5.97) 
Overweight (≥25 kg/m2) 3766 336.07 (5.52) 286.92 (218.77,393.53)  298.84 (4.11) 
Not overweight (<25 kg/m2) 6925 351.74 (5.47) 293.35 (219.62,420.61)  308.85 (4.04) 
Children (≤19 y) 
  BMI z-score Category   518 
Underweight (z < -2) 60 311.69 (26.01) 266.98 (214.27,374.60)  274.46 (24.13) 
Normal (z ≥ -2, <1) 3437 325.53 (5.81) 279.54 (210.50,387.67)  292.02 (4.35) 
Overweight (z >1, <2 852 315.05 (11.54) 269.67 (206.94,367.06)  282.02 (8.54) 
Obese (z ≥ 2) 338 327.68 (18.13) 281.71 (206.42,380.02)  295.17 (14.15) 
Not overweight (z <1) 1190 318.74 (9.68) 273.31 (206.85,374.35)  285.80 (7.28) 
Overweight/obese (z ≥ 1)   3497 325.27 (5.73) 279.33 (210.56,387.20)  291.68 (4.30) 
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Table 3 Prevalence of vitamin B12 deficiency and insufficiency    
 
  
Variable 
  Vitamin B12 deficiency (<148 pmol/L)    Vitamin B12 insufficiency (<221 pmol/L) 
n  N N 
(thousands) 
% (95% CI)  n  N N 
(thousands)  
% (95% CI)  
National 970 16152 577 5.39 (4.85-5.97)  4881 16152 2932 27.38 (25.93-28.87) 
Socio-demographic  
Sex 
     
 
     
Male 436 5853 299 5.89 (5.05-6.87)  2108 5853 1586 31.31 (29.24-33.47) 
Female 534 10299 278 4.93 (4.28-5.67)  2773 10299 1346 23.84 (22.41-25.34) 
Age Quintile 
     
 
     
Q1 (<16y) 211 3876 109 4.83 (3.91-5.94)  1265 3876 657 29.05 (26.73-31.48) 
Q2 (16-24y) 246 3144 150 6.74 (5.57-8.14)  1158 3144 761 34.12 (31.5-36.84) 
Q3 (24-32y) 176 3159 97 4.95 (4.01-6.09)  944 3159 540 27.51 (24.98-30.2) 
Q4 (32-43y) 216 3768 114 5.09 (4.15-6.23)  1028 3768 547 24.49 (22.34-26.78) 
Q5 (>43) 121 2205 106 5.26 (4.07-6.78)  486 2205 427 21.11 (18.7-23.75) 
Life stage 
     
 
     
Pregnant women  64 275 31 21.26 (14.47-30.11)  166 275 80 55.41 (45.96-64.48) 
WRA (12-49 y)  421 8996 191 4.09 (3.47-4.8)  2410 8996 1126 24.07 (22.52-25.68) 
Area± 
     
 
     
        Urban 601 9959        -- 6.03 (5.58-6.52)  3043 9959           -- 30.56 (29.66-31.47) 
        Rural 369 6193        -- 5.96 (5.4-6.58)  1838 6193           -- 29.68 (28.55-30.83) 
Region 
     
 
     
        Highlands 530 7508 331 6.8 (6.01-7.69)  2528 7508 1666 34.28 (32.25-36.36) 
        Coast 171 4546 209 3.95 (3.22-4.83)  947 4546 1083 20.45 (18.52-22.51) 
        Amazon 251 3588 37 6.78 (5.71-8.02)  1311 3588 181 33.5 (30.9-36.2) 
        Galápagos 18 510 1 3.72 (2.03-6.74)  95 510 3 19.19 (13.2-27.04) 
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Table 3 (Continued) 
Economic status index 
        Q1 220 3801 93 4.21 (3.4-5.2)  1106 3801 539 24.31 (21.91-26.88) 
        Q2 211 3593 117 5.6 (4.43-7.07)  1088 3593 553 26.45 (23.64-29.47) 
        Q3 201 3250 111 5.39 (4.32-6.7)  1035 3250 587 28.56 (25.62-31.69) 
        Q4 185 2926 130 6.21 (5.07-7.58)  886 2926 609 29 (26.23-31.93) 
        Q5 153 2575 125 5.59 (4.44-7.03)  766 2575 644 28.74 (25.71-31.98) 
Ethnicity 
     
 
     
        Indigenous 130 1676 55 6.12 (4.6-8.1)  587 1676 288 31.78 (27.14-36.83) 
        Afro-Ecuadorian 26 577 30 3.96 (2.48-6.26)  115 577 137 18.07 (14.05-22.93) 
        Montubio 22 561 31 3.6 (2.18-5.9)  130 561 180 20.76 (16.66-25.57) 
        Mestizo, white, and others 792 13338 460 5.63 (5.02-6.3)  4049 13338 2328 28.45 (26.86-30.1) 
 Level of Education 
     
 
     
        None/incomplete primary school 11 289 4 1.54 (0.75-3.12)  61 289 45 18.43 (13.35-24.88) 
        Primary school/incomplete secondary 548 9463 305 5.18 (4.51-5.94)  2915 9463 1637 27.84 (26.12-29.63) 
        Secondary school 265 4188 162 5.54 (4.63-6.61)  1232 4188 756 25.9 (23.7-28.24) 
        Greater than secondary school 146 2212 107 6.41 (4.94-8.29)  673 2212 495 29.63 (26.44-33.03) 
Anthropometric 
   
 
   
Adults (>19 y) 603 10691 
   
 2940 10691 
   
BMI Category     
 
     
        Underweight (<18.5 kg/m2) 10 131 7 6.65 (2.58-16.11)  30 131 19 19.69 (11.33-31.99) 
        Normal (18.5 - <25.0 kg/m2) 204 3635 137 5.29 (4.24-6.59)  1008 3635 669 25.84 (23.56-28.25) 
        Overweight (25.0 - <30.0 kg/m2) 271 4462 173 5.6 (4.66-6.71)  1277 4462 837 27.06 (24.84-29.4) 
        Obese (≥30.0 kg/m2 kg/m2) 118 2463 72 4.31 (3.22-5.74)  625 2463 372 22.12 (19.7-24.74) 
       Not overweight (<25 kg/m2) 214 3766 143 5.34 (4.31-6.6)  1038 3766 688 25.61 (23.36-28) 
       Overweight/obese (≥25 kg/m2) 389 6925 246 5.14 (4.42-5.98)  1902 6925 1209 25.32 (23.56-27.16) 
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±Area estimates are unweighted. 
 
 
 
 
 
 
 
 
Table 3 (Continued)            
   Children (≤19 years 265 4687     1570 4687    
Underweight (z < -2) 4 60 4 11.07 (3.2-31.96)  18 60 15 37.54 (21.64-56.68) 
Normal (z ≥ -2, <1) 191 3437 93 4.57 (3.64-5.71)  1124 3437 593 29.12 (26.71-31.66) 
Overweight (z >1, <2 51 852 31 6.24 (4.12-9.33)  315 852 167 33.23 (28.31-38.54) 
Obese (z ≥ 2) 19 338 7 3.48 (1.98-6.06)  113 338 60 29.03 (21.96-37.3) 
Not overweight (z<1) 195 3497 97 4.69 (3.75-5.85)  1142 3497 608 29.28 (26.89-31.8) 
Overweight /obese (z ≥ 1) 70 1190 38 5.43 (3.79-7.72)  428 1190 227 32 (27.92-36.38) 
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The prevalence of vitamin B12 deficiency (<148 pmol/L) and vitamin B12 insufficiency 
(<221 pmol/L) by different socio-demographic and anthropometric variables is presented 
in Table 3.  The overall prevalence of vitamin B12 deficiency was 5.4%. (95% CI: 4.9%-
6%), while vitamin B12 insufficiency was 27.4%. (95% CI: 25.9%-29%). The highest 
prevalence of vitamin B12 insufficiency was observed among pregnant women (55.4%. CI: 
46-64.5), compared to non-pregnant women of reproductive age (12-49y) (24.1%. CI: 
22.5-25.7). 
 
The correlates of natural logarithmically transformed vitamin B12 levels are presented in 
Table 4a. Men had lower vitamin B12 levels compared to women (β= -0.084, p<0.0001). 
Similarly, women of reproductive age (12-49 years) and pregnant women had lower 
vitamin B12 levels compared to women who were younger than 12 or older than 49 years 
(β=0.099, p=0.0005) and non-pregnant, respectively (β= -0.312, p<0.0001). 
 
Both region and ethnicity were significantly associated with vitamin B12 levels, while no 
significant association was observed for vitamin B12 levels and area (i.e. rural or urban). 
Univariate associations were also measured for children (10-19 y, n=5,205) and adults 
(>19y, n=10,947) separately (appendix tables 2 and 3).  
 
The associations of sociodemographic and anthropometric factors with the odds of vitamin 
B12 deficiency or insufficiency are summarized in Table 4b. Individuals in the coast has 
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lower odds of vitamin B12 deficiency 0.56 (95% CI: 0.44 , 0.72) and insufficiency (0.49, 
95%CI 0.42-0.57) when compared to individuals in the highland regions.  
The tables of the subgroup analyses for children (10-19 y) and adults (>19 y) are included 
in appendix tables 4 and 5. 
 
Table 4a Correlates of natural logarithmically transformed vitamin B12 concentrations 
Variables Beta  SE P value 
Socio-demographic 
Sex <0.0001 
            Male -0.08 0.01 <0.0001 
            Female Reference 
Age, years  0.003 0.001 <0.0001 
Age Quintiles <0.0001 
Q1 (<16y) 0.01 0.02 0.58 
Q2 (16-24y) -0.03 0.02 0.07 
Q3 (24-32y) Reference 
Q4 (32-43y) 0.06 0.02 0.0003 
Q5 (>43) 0.12 0.02 <0.0001 
Life stage 
Pregnant women  -0.31 0.05 <0.0001 
WRA (12-49y) vs. Women non WRA -0.1 0.03 0.0005 
  Area± 0.73 
        Urban Reference 
        Rural -0.01 0.02 0.73 
  Region <0.0001 
        Highlands Reference 
        Coast 0.21 0.02 <0.0001 
        Amazon 0.03 0.02 0.12 
        Galápagos 0.28 0.07 <0.0001 
Economic status index 0.15 
        Q1 Reference 
        Q2 0.001 0.02 0.98 
        Q3 -0.01 0.03 0.79 
        Q4 -0.02 0.03 0.45 
        Q5 -0.057 0.03 0.02 
  
 Table 4 (Continued) 
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Ethnicity  
<0.0001 
        Indigenous -0.06 0.02 0.01 
        Afro-Ecuadorian 0.18 0.04 <0.0001 
        Montubio 0.09 0.03 0.01 
        Mestizo, white, and others Reference 
 Level of Education  0.001 
        None/incomplete primary school Reference 
        Primary school/incomplete secondary -0.119 0.04 0.002 
        Secondary school -0.111 0.04 0.01 
        Greater than secondary school -0.162 0.04 0.0001 
Anthropometric 
Adults (>19 years) 
BMI (kg/cm2)  0.003 0.001 0.01 
  BMI category 0.0003 
      Underweight (<18.5 kg/m2) 0.100 0.06 0.11 
      Normal (18.5 - <25.0 kg/m2) Reference 
      Overweight (25.0 - <30.0 kg/m2) 0.016 0.01 0.29 
      Obese (≥30.0 kg/m2) 0.075 0.02 <0.0001 
      Overweight (≥25.0 vs not) 0.033 0.01 0.01 
Children (≤19y) 
BMI z-score Category 0.62 
Underweight (z < -2) -0.062 0.09 0.49 
Normal (z ≥ -2, <1) Reference 
Overweight (z >1, <2 -0.035 0.03 0.27 
Obese (z ≥ 2) 0.011 0.05 0.83 
Overweight or obese (z ≥ 1 vs not) -0.020 0.03 0.47 
±Area estimates are unweighted. 
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Table 4b Correlates of vitamin B12 deficiency and insufficiency 
Variable Vitamin B12 deficiency (<148 pmol/L)    Vitamin B12 insufficiency (<221 pmol/L)  
n/N OR 95% CI P  n/N OR  95% CI P  
Socio-demographic 
Sex 970/16152 0.1 4881/16152 <0.0001 
Male 436/5853 1.21 (0.97, 1.51) 0.1 2108/5853 1.46 (1.32, 1.61) <0.0001 
Female Reference 
Age, years  0.1 (0.99, 1.01) 0.1 0.99 (0.98, 0.99) <0.0001 
  Age quintiles 0.09 <0.0001 
Q1 (<16y) 211/3876 0.98 (0.73, 1.31) 0.87 1265/3876 1.08 (0.92, 1.26) 0.34 
Q2 (16-24y) 246/3144 1.39 (1.03, 1.87) 0.03 1158/3144 1.37 (1.17, 1.6) <0.0001 
Q3 (24-32y) 176/3159 Reference 944/3159 Reference  
Q4 (32-43y) 216/3768 1.03 (0.77, 1.38) 0.84 1028/3768 0.86 (0.73, 1) 0.05 
Q5 (>43) 121/2205 1.07 (0.75, 1.52) 0.72 486/2205 0.71 (0.58, 0.86) 0.0004 
Life stage 
Pregnant women  64/275 6.03 (3.63, 10.01) <0.0001 166/275 3.94 (2.67, 5.82) <0.0001 
WRA (12-49y) not pregnant 421/8996 0.58 (0.37, 0.9) 0.02 2410/8996 1.53 (1.19, 1.97) 0.001 
  Area‡ 0.84 0.24 
        Urban 601/9959 Reference 3043/9959 0.96 (0.9, 1.03) 0.24 
        Rural 369/6193 0.99 (0.86, 1.13) 0.84 1838/6193 Reference 
  Region 970/16152 <0.0001 <0.0001 
        Highlands 530/7508 Reference 2528/7508 Reference 
        Coast 171/4546 0.56 (0.44, 0.72) <0.0001 947/4546 0.49 (0.42, 0.57) <0.0001 
        Amazon 251/3588 1 (0.8, 1.25) 0.97 1311/3588 0.97 (0.83, 1.12) 0.65 
        Galápagos 18/510 0.53 (0.28, 1) 0.05 95/510 0.46 (0.29, 0.72) 0.01 
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Table 4b (Continued)          
Economic status index 970/16145 0.11 4881/16145 0.09 
        Q1 220/3801 Reference 1106/3801 Reference  
        Q2 211/3593 1.35 (0.98, 1.86) 0.07 1088/3593 1.12 (0.92, 1.36) 0.25 
        Q3 201/3250 1.3 (0.95, 1.77) 0.10 1035/3250 1.25 (1.02, 1.52) 0.03 
        Q4 185/2926 1.51 (1.11, 2.05) 0.01 886/2926 1.27 (1.05, 1.54) 0.01 
        Q5 153/2575 1.35 (0.97, 1.87) 0.08 766/2575 1.26 (1.03, 1.54) 0.03 
  Ethnicity 970/16152 0.14 <0.0001 
        Indigenous 130/1676 1.09 (0.8, 1.5) 0.58 587/1676 1.17 (0.93, 1.48) 0.19 
        Afro-Ecuadorian 26/577 0.69 (0.42, 1.13) 0.14 115/577 0.55 (0.41, 0.75) 0.0001 
        Montubio 22/561 0.63 (0.37, 1.07) 0.09 130/561 0.66 (0.5, 0.87) 0.004 
        Mestizo, white, and others 792/13338 Reference  4049/13338 Reference 
  Level of Education  970/16152 0.003 0.01 
        None/incomplete primary school 11/289 Reference 61/289 Reference 
        Primary school/incomplete secondary 548/9463 3.5 (1.68, 7.27) 0.001 2915/9463 1.71 (1.17, 2.5) 0.01 
        Secondary school 265/4188 3.75 (1.77, 7.93) 0.001 1232/4188 1.55 (1.04, 2.31) 0.03 
        Greater than secondary school 146/2212 4.39 (2.02, 9.5) 0.0002 673/2212 1.86 (1.24, 2.81) 0.003 
Anthropometric 
Adults (>19 y) 603/10691 2940/10691 
BMI 0.98 (0.96, 1.01) 0.20 0.96 (0.98, 1) 0.06 
BMI Category 0.48 0.02 
        Underweight (<18.5 kg/m2) 10/131 1.28 (0.458, 3.55) 0.64 30/131 0.70 (0.37, 1.36) 0.29 
        Normal (18.5 - <25.0 kg/m2) 204/3635 Reference 1008/3635 Reference 
        Overweight (25.0 - <30 kg/m2) 271/4462 1.06 (0.79, 1.44) 0.70 1277/4462 1.07 (0.92, 1.24) 0.41 
        Obese (≥30 kg/m2) 118/2463 0.81 (0.55, 1.19) 0.27 625/2463 0.82 (0.68, 0.97) 0.02 
        Overweight or obese (≥25 kg/m2 vs not) 389/6925 0.96 (0.73, 1.27) 0.78 1902/6925 0.99 (0.86, 1.13) 0.82 
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‡Area estimates are unweighted 
 
 
 
 
 
 
 
 
 
 
 
Table 4b (Continued)  
Children (≤19 years)  
 
265/4687 
 
 
 
1570/4687 
         BMI z-score Category 0.18 0.37 
Underweight (z < -2) 4/60 2.6 (0.68, 9.95) 0.16 18/60 1.463 (0.67, 3.22) 0.34 
Normal (z ≥ -2, <1) 191/3437 Reference 1124/3437 Reference 
Overweight (z >1, <2 51/852 1.39 (0.85, 2.28) 0.19 315/852 1.211 (0.95, 1.55) 0.12 
Obese (z ≥ 2) 19/338 0.75 (0.4, 1.41) 0.38 113/338 0.996 (0.67, 1.49) 0.98 
Overweight or obese (z ≥1) vs not 70/1190 1.17 (0.75, 1.82) 0.49 428/1190 1.137 (0.92, 1.41) 0.25 
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Findings of multivariate analyses are presented in Tables 5 a-c. When compared to people 
in the highlands, individuals living in coastal regions had higher vitamin B12 concentrations 
(β=0.21, p <0.0001) and lower odds of vitamin B12 deficiency (OR: 0.56, 95% CI: 0.44-
0.72) and vitamin B12 insufficiency (OR: 0.48, 95% CI: 0.41-0.57). Compared to women, 
men had lower levels of vitamin B12 (β= -0.09, p <0.0001) and higher odds of vitamin B12 
insufficiency (OR: 1.5, 95% CI: 1.35-1.66).  
 
In terms of age, age quintiles 4 (32-43 y) and 5 (≥ 43 y) had statistically significant higher 
vitamin B12 concentrations (β=0.06, p=0.0002, and β=0.11, p <0.0001) when compared to 
age quintile 3 (24-32 y). Similarly, compared to quintile 3, individuals in age quintiles 4 
and 5 had lower odds of vitamin B12 insufficiency (OR: 0.84, 95% CI: 0.72-0.98 and OR: 
0.70, 95% CI: 0.58-0.85, respectively), while individuals in age quintile 2 (16-24 y) had 
higher odds of vitamin B12 insufficiency (OR: 1.33, 95% 1.14-1.56). 
 
Regarding ethnicity, Afro-Ecuadorian ethnicity was associated with higher vitamin B12 
levels (β=0.13, p <0.0001) and lower odds of vitamin B12 insufficiency (OR: 0.65, 95% CI: 
0.49-0.88). 
 
Analyses within adult (>19y) and children (≤19y) subgroups and children subgroups are 
included in appendix tables 6a-c and 7a-c, respectively. The main differences between 
these subgroup models and the overall models were the inclusion of the area (i.e. urban, 
rural) correlate in the adult insufficiency model and that neither ethnicity nor education 
level were kept for any of the children-only models. 
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Table 5a Multivariate model for natural logarithmically transformed vitamin B12 
Variable F value p-value Beta SE p-value 
Sex 62.600 <0.0001  
Male -0.09 0.01 <0.0001 
Female Reference 
Age quintile 14.250 <0.0001  
Q1 (<16y) 0.01 0.02 0.76 
Q2 (16-24y) -0.03 0.02 0.13 
Q3 (24-32y)  Reference 
Q4 (32-43y) 0.06 0.02 0.0002 
Q5 (>43) 0.11 0.02 <0.0001 
Ethnicity 5.48 0.001 
    Indigenous 0.01 0.02 0.76 
    Afro-Ecuadorian 0.13 0.03 <0.0001 
    Montubio -0.01 0.03 0.86 
  Mestizo/white/others Reference 
Region 37.27 <0.0001 
Highlands Reference 
Coast 0.21 0.02 <0.0001 
Amazon 0.03 0.02 0.19 
Galápagos 0.28 0.07 <0.0001 
Level of Education 2.66 0.05 
        None/incomplete primary school Reference 
        Primary school/incomplete secondary -0.04 0.04 0.27 
        Secondary school -0.06 0.04 0.15 
        Greater than secondary school -0.09 0.04 0.02 
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Table 5b Multivariate model for vitamin B12 deficiency  
Variable OR 95% CI p-value 
Region <0.0001 
Coast 0.56 0.44 0.72 <0.0001 
Amazon 1.01 0.82 1.27 0.92 
Galápagos 0.53 0.28 0.99 0.05 
Highlands Reference 
Level of Education 0.002 
        None/incomplete primary school Reference 
        Primary school/incomplete secondary 3.58 1.72 7.46 0.0007 
        Secondary school 3.92 1.85 8.27 0.0004 
        Greater than secondary school 4.47 2.06 9.69 0.0002 
 
 
Table 5c Multivariate model for vitamin B12 insufficiency 
Variable OR 95% CI p-value 
Sex <0.0001 
Male 1.5 1.35 1.66 <0.0001 
Female Reference 
Age quintile <0.0001 
Q1 (<16y) 1.01 0.87 1.19 0.86 
Q2 (16-24y) 1.33 1.14 1.56 0.0004 
Q3 (24-32y) Reference 
Q4 (32-43y) 0.84 0.72 0.98 0.03 
Q5 (>43) 0.70 0.58 0.85 0.0003 
Region <0.0001 
   Coast 0.48 0.41 0.57 <0.0001 
   Amazon 0.99 0.84 1.16 0.88 
   Galápagos 0.46 0.28 0.73 0.001 
   Highlands Reference 
Economic quintile 0.043 
   Q1  Reference 
   Q2 1.18 0.96 1.43 0.11 
   Q3 1.33 1.07 1.65 0.004 
   Q4 1.31 1.07 1.59 0.01 
   Q5 1.11 0.89 1.38 0.26 
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Table 5c (Continued) 
Ethnicity 
 
0.05 
    Indigenous 0.97 0.76 1.24 0.82 
    Afro-Ecuadorian 0.65 0.5 0.88 0.01 
    Montubio 0.95 0.70 1.28 0.73 
   Mestizo/white/others     Reference 
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DISCUSSION 
 
 
 
Burden of vitamin B12 deficiency and vitamin B12 insufficiency  
 
In Ecuador, the prevalence of vitamin B12 deficiency is 5.4% (<148 pmol/L), while 27.4% 
of the population has vitamin B12 insufficiency  (<221 pmol/L). The prevalence of vitamin 
B12 deficiency and vitamin B12 insufficiency was highest among pregnant women (21.3% 
and 55.4%, respectively), individuals in the highands regions (6.8% and 34.3%, 
respectively), and individuals between the ages of 16 and 24 years (6.7% and 34.1%, 
respectively), compared to the general population.  
 
The prevalence of vitamin B12 deficiency and insufficiency in Ecuador is similar to the 
reported estimates for other Latin American countries(37). For Ecuadorian women of 
reproductive age (12-49 y) the prevalence of vitamin B12 deficiency (4%) is similar to the 
estimate for Costa Rican (5%) and Argentinian (3.4%) women of similar age, but lower 
than the comparable estimate for Mexican women ages 20-49y (8.5%)(38) Pregnant 
women have the highest prevalence of vitamin B12 deficiency in Ecuador (21%). This 
estimate is comparable with the 18.9% prevalence of vitamin B12 deficiency in a sample of 
pregnant women (n=1,781) from a nationally-representative survey from Colombia, but 
lower than the 30.9% estimate of vitamin B12 deficiency in Argentinian women (n=1,612) 
(Appendix table 1). 
 
The 27% overall prevalence of vitamin B12 insufficiency in Ecuador represents an 
important public health problem. It has been suggested that low vitamin B12 levels, even in 
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the absence of the classical clinical presentation of hematological or neurological 
symptoms, is associated with adverse health outcomes such as cognitive impairment in 
children(17) and older adults (19)and depression(10). This is especially a problem for 
developing infants(39), whose vitamin B12 status is largely determined by maternal vitamin 
B12 status(40, 41). The high burden of vitamin B12 deficiency during pregnancy in Ecuador 
and other Latin American countries also represents a public health problem because of the 
association of low vitamin B12 levels and adverse pregnancy outcomes (12), such as neural 
tube defects (18). 
 
Socio-demographic correlates of vitamin B12 status 
In Ecuador, men had significantly lower vitamin B12 concentrations (β= -0.09, p<0.0001) 
and higher odds for vitamin B12 insufficiency (OR: 1.5, 95% CI: 1.35-1.66) compared to 
women. This finding is inconsistent with the literature, that suggests that women have a 
higher risk of vitamin B12 deficiency(10, 20, 26, 42). It is unlikely that this observation can 
be explained by diet alone, since the ENSANUT-ECU report (32) described vitamin B12 
intake was stlightly lower in women than men.  
 
Likewise, vitamin B12 concentrations were higher among individuals in age quintiles 4 (32-
43y) (β=0.06, p=0.0002) and 5 (≥43y) (β=0.11, p <0.0001), compared to age quintile 3 (24-
32y), while odds of vitamin B12 insufficiency were higher for individuals in age quintile 2 
(16-24y) (OR: 1.33, 95% CI: 1.14-1.56) and lower for indivuals in age quintiles 4 
(OR:0.84, 95% CI: 0.72-0.98) and 5 (OR: 0.7, 95% CI: 0.58-0.85), compared to age 
quintile 3. This is also inconsistent with current literature that suggests that older adults 
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have an increased risk of vitamin B12 deficiency and vitamin B12 insufficiency due to 
inadequate intake and impaired absorption(10, 20). However, the age range is not entirely 
comparable since older adults are generally described as older than 60-65 y and people 
older than 59 years were not included in the biochemical survey of ENSANUT-ECU. 
 
Furthermore, the observation in ENSANUT-ECU that a lower economic quintile and/or 
education level were associated with higher vitamin B12 levels and improved vitamin B12 
status is also inconstintent with the literature(10, 20, 21). A national survey from 
Argentina(43), found that higher economic status was associated with improved vitamin 
B12 status in pregnant women, while no association was observed between economic status 
and vitamin B12 levels or status in non-pregnant women ages 10-49. In Costa Rica (44), 
higher education level was associated with a better vitamin B12 status in women of 
reproductive age (15-44 y) but no association was observed in men, women ages 45-64, or 
the elderly (≥65 y). It has been suggested that limited access to animal-source foods in low-
resource settings is associated with decreased vitamin B12 intake and, consequently, poor 
vitamin B12 status(10, 21).  
 
In addition, compared to individuals in the highlands region, individuals in the coast and 
Galápagos regions had higher vitamin B12 concentrations (β=0.21, p<0.0001 and β=0.28, p 
<0.0001) and lower odds of vitamin B12 deficiency (coast OR: 0.56, 95% CI: 0.44-0.72, 
Galápagos OR: 0.52, 95% CI: 0.28-0.99) and insufficiency (coast OR: 0.48, 95% CI: 0.41-
0.57, Galápagos OR: 0.46, 95% CI: 0.28-0.74). Higher fish and shellfish intake in the 
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coastal regions(32) may be associated with this finding, but this possibility has not been 
explored.  
 
On the other hand, there was no difference in vitamin B12 levels or status between urban 
and rural areas in Ecuador. This was consistent with findings from a national survey from 
Costa Rica (44), while a rural setting was associated with lower vitamin B12 levels in a 
nationally representative sample of Colombian pregnant women (45). 
 
Although, in the univariate analyses, the Indigenous population in Ecuador had lower 
vitamin B12 levels and people of Montubio and Afro-Ecuadorian ethnicity had higher 
vitamin B12 levels when compared to Mestizo or white individuals, this association was 
only significant for the Afro-Ecuadorian population in the multivariate analyses. Ethnicity, 
specifically indigenous, was a significant correlate of vitamin B12 deficiciency in pregnant 
women in Colombia(45) and Mexico(38). 
 
Body Mass Index (BMI) was not associated with vitamin B12 status in the multivariate 
analyses. Although there were some associations between BMI, BMI WHO categories, and 
BMI z-score categories and vitamin B12 status and levels in the univariate analyses, none of 
the associations remained significant in any of the multivariate models. 
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Strengths 
ENSANUT-ECU is the first nationally-representative survey in Ecuador to assess vitamin 
B12 status in the overall population. The representative sampling allows for the estimation 
of the first national-level prevalence estimate of vitamin B12 deficiency and vitamin B12 
insufficiency, as well as the prevalence of vitamin B12 deficiency and vitamin B12 
insufficiency various key risk groups, such as pregnant women and women of reproductive 
age. 
 
Limitations 
There are several limitations that constrain the interpretation of the findings of this 
analysis. Firstly, given that this is a cross-sectional study, we cannot infer temporality or 
causality of the observed associations. Furthermore, data was not available for children 
younger than 10 years, lactating women, or adults older than 60 years, all of which are 
groups at risks of vitamin B12 deficiency. Similarly, as the sample of pregnant women was 
small, the estimates of vitamin B12 deficiency and vitamin B12 insufficiency in this 
subgroup could be inaccurate.  
 
Moreover, vitamin B12 measurement was limited to one time point and no functional 
vitamin B12 biomarkers were considered. Another limitation is the lack of consideration 
folate status and functional outcomes (ie. anemia, cognitive abnormalities, growth) in this 
analysis, as well as dietary intake of animal-source foods and vitamin B12 and prescence of 
infections that may affect vitamin B12 absorption. Finally, the pregnancy variable was self-
reported and women did not know if they were or not pregnant were classified as not 
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pregnant, which could have altered the estimates of vitamin B12 deficiency and vitamin B12 
insufficiency in these subgroups. 
 
Future research recommendations 
ENSANUT-ECU is the first survey to estimate vitamin B12 status at the National level in 
Ecuador. More information is needed to estimate the burden of vitamin B12 deficiency and 
vitamin B12 insufficiency for key risk groups in Ecuador; particularly infants, children, 
pregnant women, lactating women, and the elderly. Further national surveys could 
oversample pregnant and lactating women to have more accurate estimates for these 
subgroups. Additionally, the use of a functional biomarker for vitamin B12 status (ie. 
MMA) in a future Ecuadorian National survey would be valuable to better estimate 
subclinical and functional insufficiencies of vitamin B12 in this population (14, 46, 47).  
The consideration of the folate status and functional outcomes of vitamin B12 deficiency 
and vitamin B12 insufficiency (eg. anemia, neurological and cognitive abnormalities) is 
also of interest for future analyses.  
 
Finally, although overall the prevalence of vitamin B12 deficiency was low, the high 
prevalence of vitamin B12 insufficiency in Ecuador warrants further research in this 
population. Prospective studies with functional biomarkers are needed to understand the 
role of vitamin B12 in the development of functional outcomes to inform the development 
of interventions.  
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APPENDIX 
 
 
Appendix Figure 1 ENSANUT-ECU sample selection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Socio-demographic Survey  
               (n=92,502) 
Anthropometric Survey 
(n=60,629) 
No anthropometry 
(n=31,873) 
No blood sample 
 (n=39,425) 
No blood sample 
(n=31,598) 
Biochemical Survey 
(n=21,204) 
Biochemical Survey 
(n=275) 
Available vitamin 
B12 (n=15,895) 
No vitamin B12 
(n=5,309) 
Available vitamin 
B12 (n=275) 
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Appendix Table 1 Prevalence of vitamin B12 deficiency and insufficiency in national surveys from Latin American Countries  
 
Country 
(Year) 
Survey 
Definition of 
vitamin B12 
status  
Population 
Prevalence of 
deficiency 
Prevalence of 
insufficiency 
Other findings 
Argentina  
(2007) 
ENNyS(43) 
Deficiency: 
<150 pg/mL  
(110.7 pmol/L) 
 
Insufficiency: 
<200 pg/mL 
(147.6 pmol/L) 
N=6,605 
women 10-49y 
3.4% 
 
 
11.9% 
 
 
No statistically significant 
differences of median vitamin B12 
between different levels of  
economic status. 
25.8% of women ages 10-29 had 
inadequate vitamin B12 intake (<2.4 
μg/d). 
Inadequate intake of vitamin B12  
was significantly higher in 
indidivuals in households with 
unsatisfied basic needs compared to 
without unsatisfied basic needs  
(7.7%. 95%CI: 6-9.8%) ,(3.1%. 
95% CI: 2.5%-3.9%), respectively. 
N= 1,612 
pregnant 
women 
18.2% 30.9% 
Chile 
(2009) 
ENS(48) 
Deficiency:  
≤200 pg/mL 
(147.6 pmol/L) 
 
Insufficiency: 
<299.5 pg/mL 
(221 pmol/L) 
N=817 adults 
≥65 y 
8.1% 33.6% 
For the ≥75y age group, women 
had a significantly lower 
prevalence of insufficiency than 
men (26.2% vs 45.3%, p=0.037). 
No other age sex differences were 
observed. 
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Appendix table 1 (Continued) 
       
 
Colombia 
(2010) 
 
ENSIN(45, 49, 
50) 
Deficiency: 
<148 pmol/L 
 
 
 Insufficiency: 
<221 pmol/L 
N=7243  
children <18y 
2.8%  18.2% 
Overall :6.6% deficiency, 22.5% 
insufficiency. 
Serum vitamin B12 was 12 pmol/L 
higher in girls than boys (p=0.004) 
and 21 pmol/L lower in children 
from households with severe food 
insecurity (p=0.003) compared to 
children from households without 
food insecurity. 
In pregnant women, university 
education of the household head 
was associated with 24 pmol/L 
higher vitamin B12 compared to 
houshold head having less than 
primary education. Living in the 
National territories, the Eastern or 
the Pacific regions was associated 
with significantly 
lower serum vitamin B12 levels than 
living in 
other regions. 
 
N=1,781 
pregnant 
women 
18.9% 41.3% 
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Appendix table 1 (Continued)    
 
Costa Rica 
(2008) 
ENN(44) 
Deficiency: 
<193 pg/mL 
(142.4 pmol/L) 
n=600 Women 
15-44y 
4.8% 
 
N/A 
Overall prevalence of deficiency 
was 4.6% 
n=750 women 
45-64y 
6.4% 
 
n=600 men 20-
64y 
2.9% 
 
n=500 ≥65y 5.3% 
Ecuador  
(2011) 
SABE II(29) 
Deficiency: 
 <200 pg/mL 
(148 pmol/L) 
n=1,065 men 
≥60y 
 
13.5% men 
 
 
 
Adults represented the coastal and 
Andes (highlands) regions. 
Mean(SE) vitamin B12 was higher 
among women than men: 527.7 
(261.6) pg/mL vs 423 (234.6) 
pg/mL, p<0.0001 
n=1,307 women 
≥60y 
6.6% women 
Mexico 
 
ENSANUT (38, 
51) 
Deficiency: 
<200 pg/mL 
N=2, 678 
children 1-5 y  
 
1.9%  
 
N/A 
Odds of  vitamin B12 deficiency 
was lower for children living the 
south compared to living in the 
center (OR: 0.22, 95% CI: 0.05-
0.95) and for children in the second 
tertile of socioeconomic status 
compared to the first tertile (OR: 
0.07, 95% CI: 0.01-0.58) 
Odds for vitamin B12 deficiency 
was higher for  indigenous 
  46
compared to non-indigenous 
children 8.7(3.2-23.62) 
N=4,275 
children 5-12y 
2.6 % 
OR for vitamin B12 deficiency was 
0.27(0.1-0.72) and 0.21 (0.06-0.69) 
for in the second and third tertile of 
socioeconomic status, compared to 
the first. 
indigenous 
children (OR=2.7, 95%CI 1.3-5.6). 
N=4,263 
women 20-49y 
8.5% 
The prevalence of vitamin B12 
deficiency was significantly higher 
in rural compared to urban areas 
(13.2% vs 7.4% and  indigenous 
compared to non-indigenous 
women (18.6% vs 7.4%). The odds 
of vitamin B12 deficiency were 
higher for women in Center, 
Mexico City, and the South 
compared to the north, 
socioeconomic quintile 5 compared 
to 1 (0.15, 95% CI: 0.06-0.40), 
       
ENNyS: National Survey of Health and (Nutrition Encuesta Nacional de Nutrición y Salud, Argentina) 
ENS: National Nutrition Survey (Encuesta Nacional de Salud, Chile) 
ENSIN: National Survey of Nutrition Situation (Encuesta Nacional de Situación Nutricional, Colombia)  
ENN: National Nutrition Survey (Encuestra Nacional de Nutrición, Costa Rica) 
ENSANUT: National Health and Nutrition Survey (Enscuesta Nacional de Salud y Nutrición, México) 
 
 
 
 
 
Appendix table 1 (Continued)  
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Appendix Table 2 Adult (>19y) subgroup analysis of correlates of natural logarithmically transformed vitamin B12 concentrations 
Variables Beta  SE P value 
Socio-demographic 
Sex <0.0001 
Male -0.06 0.02 <0.0001 
Female Reference 
Age, years  0.01 0.001 <0.0001 
Age Categories <0.0001 
20-29 -0.05 0.02 0.01 
30-39 Reference 
40-49 0.05 0.02 0.01 
50-59 0.10 0.03 0.001 
Life stage 
Pregnant women  -0.32 0.05 <0.0001 
WRA (12-49y) vs. Women non WRA -0.10 0.04 0.01 
  Area 0.63 
        Urban Reference 
        Rural 0.01 0.02 0.63 
  Region <0.0001 
        Highlands Reference 
        Coast 0.21 0.02 <0.0001 
        Amazon 0.07 0.02 0.0003 
        Galápagos 0.28 0.06 <0.0001 
Economic status index 0.05 
        Q1 Reference 
        Q2 0.003 0.03 0.92 
        Q3 -0.002 0.03 0.96 
        Q4 -0.034 0.03 0.18 
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        Appendix table 2 (Continued) 
Q5 -0.07 0.03 0.01 
  Ethnicity <0.0001 
        Indigenous -0.04 0.03 0.11 
Appendix Table 2. (Continued)    
        Afro-Ecuadorian 0.18 0.04 <0.0001 
        Montubio 0.07 0.04 0.06 
        Mestizo, white, and others Reference 
  Level of Education  0.0001 
        None/incomplete primary school Reference 
        Primary school/incomplete secondary -0.08 0.04 0.03 
        Secondary school -0.11 0.04 0.01 
        Greater than secondary school -0.16 0.04 0.0001 
Anthropometric 
BMI (kg/cm2)  0.003 0.001 0.01 
  BMI category 0.0003 
      Underweight (<18.5 kg/m2) 0.10 0.06 0.11 
      Normal (18.5 - <25 kg/m2) Reference 
      Overweight (25 - <30 kg/m2) 0.02 0.01 0.29 
      Obese (≥30kg/m2) 0.08 0.02 <0.0001 
      Overweight (≥25 kg/m2 vs not) 0.03 0.01 0.01 
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Appendix Table 3 Children (≤19y) Correlates of natural logarithmically transformed vitamin B12 concentrations 
Variables Beta  SE P value 
Socio-demographic 
Sex <0.0001 
Male -0.12 0.02 <0.0001 
Female Reference 
Age, years  -0.02 0.003 <0.0001 
Life stage 
Pregnant women  -0.27 0.17 0.03 
WRA (12-49y) vs. Women non WRA -0.10 0.03 0.001 
  Area 0.12 
        Urban Reference 
        Rural -0.04 0.03 0.12 
  Region <0.0001 
        Highlands Reference 
        Coast 0.21 0.03 <0.0001 
        Amazon -0.06 0.02 0.01 
        Galápagos 0.29 0.08 0.001 
Economic status index 0.66 
        Q1 Reference 
        Q2 0.00 0.03 0.92 
        Q3 -0.02 0.03 0.51 
        Q4 0.02 0.04 0.60 
        Q5 -0.02 0.03 0.49 
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Appendix Table 3 (Continued)  
 
Ethnicity 
 
 
<0.0001 
        Indigenous -0.11 0.04 0.003 
        Afro-Ecuadorian 0.18 0.06 0.003 
        Montubio 0.14 0.04 0.001 
        Mestizo, white, and others Reference 
  Level of Education  0.43 
        None/incomplete primary school Reference 
        Primary school/incomplete secondary -0.08 0.32 0.81 
        Secondary school -0.15 0.32 0.64 
        Greater than secondary school -0.11 0.33 0.74 
Anthropometric 
BMI z-score Category 0.62 
Underweight (z < -2) -0.06 0.09 0.49 
Normal (z ≥ -2, <1) Reference 
Overweight (z >1, <2 -0.03 0.03 0.27 
Obese (z ≥ 2) 0.01 0.05 0.83 
Overweight or obese (z ≥ 1) vs not -0.02 0.03 0.47 
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Appendix Table 4 Adult subgroup correlates of vitamin B12 deficiency and insufficiency 
Variable 
Vitamin B12 deficiency (<148 pmol/L)  Vitamin B12 insufficiency (<221 pmol/L)  
n/N OR 95% CI P  n/N OR  95% CI P  
Socio-demographic 
Sex 663/10947 0.72 3092/10947 <0.0001 
Male 239/3366 1.05 (0.81, 1.37) 0.72 1118/3366 1.32 (1.16, 1.51) <0.0001 
Female Reference 1974/7581 
Age, years  0.99 (0.98, 1) 0.16 0.98 (0.97, 0.99) <0.0001 
  Age categories <0.0001 <0.0001 
20-29 263/3762 1.06 (0.8, 1.41) 0.68 1212/3762 1.19 (1.02, 1.39) 0.30 
30-39 220/3794 Reference 1078/3794 
40-49 132/2642 0.64 (0.45, 0.91) 0.01 646/2642 0.83 (0.7, 0.99) 0.04 
50-59 48/749 1.07 (0.68, 1.69) 0.77 156/749 0.7 (0.54, 0.91) 0.01 
Life stage 
Pregnant women  59/236 6.03 (3.63, 10.01) <0.0001 147/236 3.9 (2.58, 5.9) <0.0001 
WRA (12-49y) not pregnant 331/6906 5.66 (3.42, 9.38) 0.002 1752/6906 1.51 (1.08, 2.12) 0.02 
  Area‡ 0.70 0.03 
        Urban 421/6874 Reference 1990/6874 Reference 
        Rural 242/3831 0.97 (0.82, 1.14) 0.70 1102/4073 0.91 (0.84, 0.99) 0.03 
  Region <0.0001 <0.0001 
        Highlands 374/5225 Reference 1676/5225 Reference 
        Coast 120/3039 0.53 (0.4, 0.71) <0.0001 601/3039 0.48 (0.41, 0.57) <0.0001 
        Amazon 161/2356 1 (0.77, 1.3) 0.97 764/2356 0.85 (0.72, 1) 0.06 
        Galápagos 8/327 0.44 (0.2, 0.98) 0.051 51/327 0.42 (0.26, 0.66) 0.0002 
Economic status index 0.10 0.01 
        Q1 147/2567 Reference 682/2567 Reference  
        Q2 139/2392 1.3 (0.89, 1.89) 0.18 678/2392 1.2 (0.97, 1.49) 0.09 
        Q3 132/2166 1.3 (0.89, 1.89) 0.18 631/2166 1.3 (1.04, 1.65) 0.02 
        Q4 131/2012 1.65 (1.15, 2.36) 0.01 586/2012 1.47 (1.19, 1.82) 0.0003 
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‡Estimates for area are not weighted 
 
 
 
 
 
 
  Appendix Table 4 (Continued)      
 Q5 114/1804 1.44 (0.99, 2.1) 0.06 515/1804 1.39 (1.1, 1.74) 0.01 
  Ethnicity 0.21 0.001 
        Indigenous 88/1138 1.03 (0.7, 1.51) 0.88 350/1138 1.01 (0.78, 1.32) 0.93 
        Afro-Ecuadorian 17/410 0.6 (0.31, 1.16) 0.13 74/410 0.52 (0.37, 0.74) 0.0003 
        Montubio 15/379 0.6 (0.31, 1.17) 0.13 91/379 0.72 (0.53, 0.99) 0.04 
        Mestizo, white, and others 543/9020 Reference  2577/9020 Reference 
  Level of Education  0.003 0.01 
        None/incomplete primary school 11/284 Reference 60/284 Reference 
        Primary school/incomplete secondary 263/4527 3.47 (1.65, 7.3) 0.001 1237/4527 1.47 (1, 2.17) 0.05 
        Secondary school 249/4016 3.73 (1.76, 7.9) 0.0006 1159/4016 1.53 (1.02, 2.29) 0.04 
        Greater than secondary school 140/2120 4.41 (2.03, 9.56) 0.0002 636/2120 1.86 (1.23, 2.82) 0.003 
Anthropometric 
BMI 0.98 (0.96, 1.01) 0.20 0.99 (0.98, 1) 0.06 
BMI Category 0.48 0.02 
        Underweight (<18.5 kg/m2) 1.28 (0.46, 3.55) 0.64 0.70 (0.37, 1.36) 0.29 
        Normal (18.5 - <25.0 kg/m2) Reference Reference 
        Overweight (25.0 - <30.0 kg/m2) 1.06 (0.79, 1.44) 0.70 1.07 (0.92, 1.24) 0.41 
        Obese (≥30.0 kg/m2) 0.81 (0.55, 1.19) 0.27 0.82 (0.68, 0.97) 0.02 
        Overweight or obese (≥25.0 vs not) 0.96 (0.73, 1.27) 0.78 0.99 (0.86, 1.13) 0.82 
  53
Appendix table 5 Child (≤ 19y) of vitamin B12 deficiency and insufficiency  
Variable 
Vitamin B12 deficiency (<148 pmol/L)    Vitamin B12 insufficiency (<221 pmol/L)  
n/N OR 95% CI P    n/N OR  95% CI P  
Socio-demographic 
Sex 307/5205 0.002 1789/5205 <0.0001 
Male 197/2487 1.88 (1.27, 2.78) 0.002 990/2487 1.71 (1.44, 2.03) <0.0001 
Female Reference 799/2718 
Age, years  1.07 (1.01, 1.13) 0.02 1.11 (1.08, 1.14) <0.0001 
Life stage 
Pregnant women  05//39 9.16 (1.94, 43.26) 0.01 19/39 4.08 (1.45, 11.51) 0.34 
WRA (12-49y) not pregnant 90/2090 1.66 (0.78, 3.54) 0.19 658/2090 1.64 (1.22, 2.21) 0.01 
  Area‡ 0.81 
        Urban 180/3085 Reference 1053/3085 Reference  
        Rural 127/2120 1.03 (0.81, 1.3) 0.81 736/2120 1.03 (0.91, 1.15) 0.66 
  Region 0.22 <0.0001 
        Highlands 156/2283 Reference 852/2283 Reference 
        Coast 51/1507 0.65 (0.42, 1.01) 0.05 346/1507 0.52 (0.42, 0.64) <0.0001 
        Amazon 90/1232 1.02 (0.71, 1.46) 0.93 547/1232 1.17 (0.94, 1.45) 0.15 
        Galápagos 10/183 0.77 (0.32, 1.84) 0.56 44/183 0.52 (0.3, 0.89) 0.02 
Economic status index 0.66 0.70 
        Q1 73/1232 Reference 424/1234 Reference 
        Q2 72/1201 1.48 (0.89, 2.46) 0.13 410/1201 0.98 (0.72, 1.32) 0.87 
        Q3 69/1084 1.30 (0.76, 2.23) 0.34 404/1084 1.15 (0.86, 1.55) 0.35 
        Q4 54/914 1.15 (0.66, 1.99) 0.62 300/914 0.94 (0.69, 1.29) 0.70 
        Q5 39/771 1.11 (0.63, 1.96) 0.72 251/771 1.05 (0.76, 1.46) 0.76 
  0.63 0.00 
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‡Area estimates are not weighted 
*Unreliable estimates because of small sample size of reference category 
 
 
 
 
 
 
Appendix table 5 (Continued) 
 Ethnicity 
    
        Indigenous 42/438 1.27 (0.77, 2.09) 0.35 237/538 1.54 (1.13, 2.1) 0.01 
        Afro-Ecuadorian 9/167 0.97 (0.44, 2.16) 0.95 41/167 0.65 (0.41, 1.04) 0.07 
        Montubio 7/182 0.69 (0.29, 1.67) 0.41 39/182 0.53 (0.34, 0.84) 0.01 
        Mestizo, white, and others 249/4318 Reference  1472/4318 Reference 
  Level of Education  0.86 
        None/incomplete primary school 0/5 Reference 1//5 Reference 
        Primary school/incomplete secondary 285/4936 --* --   -- 1678/4936 1.26 (0.13, 12.07) 0.84 
        Secondary school 16/172        -- --   -- 73/172 1.51 (0.15, 15.11) 0.73 
        Greater than secondary school 6//92        --            --   -- 37/92 1.37 (0.13, 14.19) 0.79 
Anthropometric 
  BMI z-score Category 0.02 0.37 
Underweight (z < -2) 1.04 (1.006, 1.08) 0.18 18/60 1.46 (0.67, 3.22) 0.34 
Normal (z ≥ -2, <1) 2.6 1124/3437 Reference 
Overweight (z >1, <2 Reference (0.68, 9.95) 0.16 315/852 1.21 (0.95, 1.55) 0.12 
Obese (z ≥ 2) 1.39 (0.85, 2.28) 0.19 113/338 1 (0.67, 1.49) 0.98 
Overweight or obese (z ≥ 1) vs not 1.17 (0.75, 1.82) 0.49 428/1190 1.14 (0.92, 1.41) 0.25 
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Appendix tables 6a-c. Adult (>19y) multivariate models. 
 
 
Appendix table 6a Adult-only multivariate model for natural logarithmically transformed vitamin B12 
Variable F value p-value Beta SE p-value 
Sex 25.280 <0.0001  
Male -0.07 0.01 <0.0001 
Female Reference 
Age, years 32.130 <0.0001 0.004 0.001 <0.0001 
Ethnicity 5.48 0.001 
    Indigenous 0.02 0.03 0.50 
    Afro-Ecuadorian 0.12 0.04 0.001 
    Montubio -0.03 0.04 0.44 
  Mestizo, white, and others Reference 
Region 37.27 <0.0001 
Highlands Reference 
Coast 0.21 0.02 <0.0001 
Amazon 0.06 0.02 0.002 
Galápagos 0.27 0.06 <0.0001 
Level of Education 2.66 0.05 
        None/incomplete primary school Reference 
        Primary school/incomplete secondary -0.04 0.04 0.34 
        Secondary school -0.06 0.04 0.16 
        Greater than secondary school     -0.10 0.04 0.02 
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Appendix Table 6b Adult-only multivariate model for vitamin B12 deficiency  
Variable OR 95% CI p-value 
Age category <0.0001 
20-29 1.02 0.76 1.35 0.9188 
30-39 Reference 
40-49 0.65 0.46 0.92 0.0145 
50-59 1.16 0.72 1.86 0.542 
Region <0.0001 
Coast 0.53 0.40 0.71 <0.0001 
Amazon 1.01 0.78 1.32 0.931 
Galápagos 0.43 0.19 0.94 0.0352 
Highlands Reference 
Level of Education 0.0033 
        None/incomplete primary school Reference 
Primary school/incomplete secondary 3.53 1.65 7.56 0.0012 
        Secondary school 3.97 1.82 8.65 0.0005 
        Greater than secondary school 4.54 2.03 10.17 0.0002 
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Appendix Table 6c Adult-only multivariate model for vitamin B12 insufficiency 
Variable OR 95% CI p-value  
Sex <0.0001 
Male 1.39 1.21 1.58 <0.0001 
Female Reference 
Age category <0.0001 
20-29 1.16 1 1.35 0.06 
30-39 Reference 
40-49 0.83 0.69 0.99 0.04 
50-59 0.70 0.54 0.91 0.01 
Area 
Urban  Reference 
Rural  0.74 0.63 0.87 0.0003 
Region <0.0001 
Coast 0.45 0.37 0.54 <0.0001 
Amazon 0.97 0.82 1.16 0.76 
Galápagos 0.45 0.28 0.71 0.001 
Highlands Reference 
Ethnicity <0.0001 
    Indigenous 0.86 0.66 1.14 0.29 
    Afro-Ecuadorian 0.61 0.43 0.87 0.01 
    Montubio 1.09 0.78 1.51 0.62 
  Mestizo/white/others Reference 
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Appendix tables 7a-c Children-only (≤19y) multivariate models. 
 
 
 
 
 
 
 
 
Appendix table 7a Children-only multivariate model for natural logarithmically transformed vitamin B12 
Variable F value p-value Beta SE p-value 
Sex 48.790 <0.0001  
Male -0.13 0.02 <0.0001 
Female Reference 
Age, years 44.070 <0.0001 -0.02 0.003 <0.0001 
Region 39.21 <0.0001 
Highlands Reference 
Coast 0.21 0.03 <0.0001 
Amazon -0.05 0.02 0.01 
Galápagos 0.28 0.08 0.001 
Appendix table 7b Children-only multivariate model for vitamin B12 deficiency  
Variable OR 95% CI p-value 
Sex 0.001 
Male 1.94 1.32 2.86 0.001 
Female Reference 0.01 
Age, years 1.08 1.02 1.14 0.01 
 
 
Appendix table 7c Children-only multivariate model for vitamin B12 insufficiency 
Variable OR 95% CI p-value  
Sex <0.0001 
Male 1.86 1.56 2.22 <0.0001 
Female Reference 
Age years 1.13 1.09 1.16 <0.0001 
Region <0.0001 
Coast 0.49 0.39 0.61 <0.0001 
Amazon 1.16 0.93 1.46 0.19 
Galápagos 0.51 0.29 0.89 0.02 
Highlands Reference 
